Recent research has shed light on the connection between per- and polyfluoroalkyl substances (PFAS) exposure and the increased risk of developing type 2 diabetes (T2D). This study, conducted by experts at the Icahn School of Medicine at Mount Sinai, delved into the metabolic disruptions caused by PFAS, highlighting the potential role of these ‘forever chemicals’ in diabetes development.
By analyzing data from over 65,000 patients in the BioMe biobank, the researchers identified a significant link between PFAS levels and T2D incidence, particularly in diverse US populations. Through in-depth metabolomic profiling, the study uncovered specific metabolites and disrupted metabolic pathways associated with PFAS exposure and diabetes risk. These findings offer valuable insights for designing targeted interventions aimed at preventing T2D by considering environmental chemical exposures alongside genetic, clinical, and lifestyle factors.
Read more from ajmc.com